Clinical Infectious Diseases (@CIDJournal) header
Clinical Infectious Diseases (@CIDJournal) profile picture

The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @IDSAinfo

Joined February 2022
Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)Photo by Clinical Infectious Diseases (@CIDJournal)
Managing HIV in Primary Care with Project ECHO: Highlighting a Successful Delivery Model ✅ Just Accepted 🔗 bit.ly/4BBZf6h
1
1
464
CID extends another round of congratulations to our 2025 Reviewers of the Year! 🎉 First announced in Feb. 2026, the awardees are: -Nicolás Cortés-Penfield, MD, FACP, FIDSA -Esteban Martinez, MD, PhD -Jose F. Portugal Gonzales, MD Learn more: bit.ly/4aoKJ6S
1
1
9
987
Cefepime–Zidebactam for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria, Including Metallo-β-Lactamase Producers: A Phase 2, Open-Label, Single-Arm, Multicenter Study ✅ Just Accepted ⭐ Editor's Choice 🔗 bit.ly/47KCJKQ
1
15
1
34
2,736
Clinical Infectious Diseases retweeted
On IDSA’s & @HIVMA’s Science Speaks blog: Check out insights from the editors of a new, ongoing series of articles in @CIDJournal highlighting how experienced clinicians deploy problem-solving skills to navigate complex cases. bit.ly/48mkxr0
4
11
1,560
Availability of IV Artesunate for Severe Malaria ✅ Just Accepted 🔗 bit.ly/4kmyzQE
1
10
945
In Reply: Clarifying the Analysis Population and Sensitivity Analyses in the SUPLA Trial ✅ Just Accepted 🔗 bit.ly/4yMrIDE
1
1
1
832
Post-randomization exclusions and estimand clarity in a trial of direct long-acting cabotegravir/rilpivirine initiation ✅ Just Accepted 🔗 bit.ly/4eS3alx
1
2
794
Geographic Differences Among Tetanus Cases—United States, 2009–2023 ✅ Just Accepted 🔗 bit.ly/4zSY4h3
2
8
1,138
Interpreting Albumin-Carbapenem Effect Modification: Functional Form, Time Zero, and Local Overlap ✅ Just Accepted 🔗 bit.ly/3U3AbV0
6
8
1,422
Association Between Neighbourhood-level Antibiotic Utilization and the Rate of Community-Associated C. difficile (CA-CDI) Infection: An Ecological Study ✅ Just Accepted 🔗 bit.ly/4yI1fqX
2
3
947
What Follows an Antibiotic Is Not Necessarily Caused by It ✅ Just Accepted 🔗 bit.ly/4exqmWb
4
11
1,370
Ertapenem in Hypoalbuminemia: Methodological and Pharmacokinetic Considerations ✅ Just Accepted 🔗 bit.ly/4zQVjNh
8
31
2,813
Hypoalbuminemia and Pharmacokinetics: Revisiting Fundamental Principles and Clinical Perspectives ✅ Just Accepted 🔗 bit.ly/47BCXUx
11
29
2,131
Antibiotic Stewardship, Resistance, and Mortality in Vancomycin-Resistant Enterococcus: A Quasi-Experimental Study of Linezolid Restrictions ✅ Just Accepted ⭐ Editor's Choice 🔗 bit.ly/4BcHhqZ
6
15
1,363
The Piperacillin-Tazobactam MIC Behaves Like a Prognostic Marker, Not a Pharmacodynamic Exposure ✅ Just Accepted 🔗 bit.ly/4zKnrSg
3
29
2,752
The piperacillin-tazobactam is behaving like a prognostic factor, but that does not negate the pharmacodynamic hypothesis ✅ Just Accepted 🔗 bit.ly/3VXonUL
3
8
1,887
HIV and Cancer Progression: Interpreting Real-World Evidence ✅ Just Accepted 🔗 bit.ly/47vVAZW
2
7
1,020
Randomized Trial Comparing Minocycline-EDTA-Ethanol Lock to Standard-of-Care Antibiotic Lock for Management of Central Line–Associated Bloodstream Infection ✅ Just Accepted 🔗 bit.ly/4yUq7wp
3
5
33
2,519